IL6 and acute respiratory distress syndrome: Therefore, based on IL-6 and TNF-α, this study aimed to uncover the regulatory mechanisms of HSBDF and its active compounds in plasma against ALI by the integrated strategy of molecular docking, LC/MS, network pharmacology, and in vitro approaches, which provide the basic data for further scientific research and clinical use of HSBDF in treating ALI.